Pregled bibliografske jedinice broj: 1029285
Melatonin and sleep quality in patients with oral cancer
Melatonin and sleep quality in patients with oral cancer // Zbornik sažetaka
Zagreb, 2019. str. 99-99 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 1029285 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Melatonin and sleep quality in patients with oral
cancer
Autori
Salarić, Ivan ; Lovrić, Jasna ; Karmelić, Ivana ; Baždarić, Ksenija ; Rožman, Marko ; Brajdić, Davor ; Zajc, Ivan ; Macan, Darko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Zbornik sažetaka
/ - Zagreb, 2019, 99-99
Skup
9. hrvatski kongres farmakologije = 9th Croatian Congress of Pharmacology
Mjesto i datum
Zagreb, Hrvatska, 25.09.2019. - 28.09.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
melatonin ; saliva ; oral cancer
Sažetak
Introduction: Low levels of melatonin (MLT) have been registered in patients with breast, prostate, lung, stomach and colon cancer. One of explanations for this was decreased sleep quality and increased fatigue in cancer patients. Although there is a significant improvement in oral cancer (OC) treatment in the last few years, a 5-year survival rate of these patients amounts to 60%. The aim of this research was to measure MLT in unstimulated whole saliva (UWS), stimulated whole saliva (SWS) and serum. Furthermore, the aim was to assess sleep quality using the Pittsburgh Sleep Quality Index (PSQI). Materials and methods: Altogether, 34 patients with OC and 33 sex and age matched healthy control subjects were included in this study. All samples were tested using ELISA commercially available kits. Results: Melatonin levels in UWS were significantly higher (P<0.001) in the OC group [median: 3.1 (95% CI: 2.3-4.5)] compared to the control group [median: 0.7 (95% CI: 0.44- 1.52)]. Melatonin levels in the SWS were significantly higher (P<0, 001) in the experimental group [median: 1.7 (95% CI: 0.9- 2.6)] compared to the control group [median: 0.6 (95% CI: 0.1-1.0)]. Serum MLT levels were significantly higher in patients with OC compared to the reference values for serum MLT [median 13, 01 (95% CI: 10, 08 - 15, 14)]. Sleep quality was significantly lower in patients with OC (P = 0.0001, U=249.50). Conclusion: Salivary and serum MLT could present a potential diagnostic marker for OC. To our knowledge, this is the first study measuring MLT in OC patients.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti, Temeljne medicinske znanosti, Kliničke medicinske znanosti, Dentalna medicina
POVEZANOST RADA
Projekti:
HRZZ-IP-09-2014-9376
Ustanove:
Medicinski fakultet, Rijeka,
Stomatološki fakultet, Zagreb,
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"
Profili:
Ksenija Baždarić
(autor)
Jasna Lovrić
(autor)
Ivana Karmelić
(autor)
Ivan Salarić
(autor)
Davor Brajdić
(autor)
Darko Macan
(autor)
Ivan Zajc
(autor)
Marko Rožman
(autor)